Peter Bühlmayer

1.1k total citations
15 papers, 882 citations indexed

About

Peter Bühlmayer is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Peter Bühlmayer has authored 15 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Organic Chemistry. Recurrent topics in Peter Bühlmayer's work include Renin-Angiotensin System Studies (7 papers), Receptor Mechanisms and Signaling (5 papers) and Heart Failure Treatment and Management (3 papers). Peter Bühlmayer is often cited by papers focused on Renin-Angiotensin System Studies (7 papers), Receptor Mechanisms and Signaling (5 papers) and Heart Failure Treatment and Management (3 papers). Peter Bühlmayer collaborates with scholars based in Switzerland and United States. Peter Bühlmayer's co-authors include Marc de Gasparo, Leoluca Criscione, Steven Whitebread, Jeanette M. Wood, Felix Waldmeier, H. Rüeger, James L. Stanton, H.‐P. KRIEMLER, Gérard Flesch and T. WINKLER and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Peter Bühlmayer

15 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bühlmayer Switzerland 12 440 334 188 182 64 15 882
John D. Irvin United States 14 384 0.9× 271 0.8× 177 0.9× 147 0.8× 53 0.8× 30 955
Hiroaki Yanagisawa Japan 17 264 0.6× 411 1.2× 403 2.1× 147 0.8× 45 0.7× 46 998
Yasuhisa Kohara Japan 9 370 0.8× 359 1.1× 473 2.5× 213 1.2× 45 0.7× 14 1.0k
Bruce H. Migdalof United States 17 270 0.6× 324 1.0× 78 0.4× 87 0.5× 44 0.7× 39 1.0k
Roger A. Burges United Kingdom 19 507 1.2× 499 1.5× 206 1.1× 39 0.2× 143 2.2× 27 1.1k
K. J. Kripalani United States 14 189 0.4× 227 0.7× 54 0.3× 90 0.5× 26 0.4× 25 700
J.‐M. POIRIER France 16 221 0.5× 143 0.4× 122 0.6× 38 0.2× 20 0.3× 38 697
Lisa E. Hernandez United States 16 118 0.3× 267 0.8× 134 0.7× 53 0.3× 62 1.0× 25 856
Piero Melloni Italy 16 121 0.3× 429 1.3× 247 1.3× 127 0.7× 57 0.9× 43 725
J. Augustín Germany 19 274 0.6× 309 0.9× 99 0.5× 316 1.7× 8 0.1× 46 1.2k

Countries citing papers authored by Peter Bühlmayer

Since Specialization
Citations

This map shows the geographic impact of Peter Bühlmayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bühlmayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bühlmayer more than expected).

Fields of papers citing papers by Peter Bühlmayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bühlmayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bühlmayer. The network helps show where Peter Bühlmayer may publish in the future.

Co-authorship network of co-authors of Peter Bühlmayer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bühlmayer. A scholar is included among the top collaborators of Peter Bühlmayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bühlmayer. Peter Bühlmayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Thoma, Gebhard, Joachim Blanz, Peter Bühlmayer, et al.. (2014). Syk inhibitors with high potency in presence of blood. Bioorganic & Medicinal Chemistry Letters. 24(10). 2278–2282. 17 indexed citations
2.
Waldmeier, Felix, Gérard Flesch, T. WINKLER, et al.. (1997). Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose. Xenobiotica. 27(1). 59–71. 118 indexed citations
3.
Criscione, Leoluca, William A. Bradley, Peter Bühlmayer, et al.. (1995). Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist. Cardiovascular Drug Reviews. 13(3). 230–250. 116 indexed citations
4.
Bühlmayer, Peter, Leoluca Criscione, Marc de Gasparo, et al.. (1994). Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series. Bioorganic & Medicinal Chemistry Letters. 4(1). 29–34. 82 indexed citations
5.
Criscione, Leoluca, et al.. (1993). Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtype. British Journal of Pharmacology. 110(2). 761–771. 225 indexed citations
6.
Bühlmayer, Peter. (1992). Patent Update: Angiotensin-II Antagonists: Patent Activity since the Discovery of DuP-753. 2(10). 1693–1718. 32 indexed citations
7.
Bühlmayer, Peter, Leoluca Criscione, Walter Fuhrer, et al.. (1991). Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives. Journal of Medicinal Chemistry. 34(10). 3105–3114. 29 indexed citations
8.
Criscione, Leoluca, Steven Whitebread, Marc de Gasparo, et al.. (1990). Binding Characteristics and Vascular Effects of Various Angiotensin II Antagonists. Journal of Cardiovascular Pharmacology. 16(Supplement 4). S56–S59. 48 indexed citations
9.
Wood, J M, Leoluca Criscione, Marc de Gasparo, et al.. (1989). CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.. PubMed. 14(2). 221–6. 37 indexed citations
10.
Wood, Jeanette M., Leoluca Criscione, Marc de Gasparo, et al.. (1989). CGP 38 560. Journal of Cardiovascular Pharmacology. 14(2). 221–226. 28 indexed citations
11.
Bühlmayer, Peter, Alessandro Caselli, Walter Fuhrer, et al.. (1988). Synthesis and biological activity of some transition-state inhibitors of human renin. Journal of Medicinal Chemistry. 31(9). 1839–1846. 90 indexed citations
12.
Trost, Barry M., Michael K. Mao, James M. Balkovec, & Peter Bühlmayer. (1986). A total synthesis of plumericin, allamcin, and allamandin. Part 1. Basic strategy. Journal of the American Chemical Society. 108(16). 4965–4973. 37 indexed citations
13.
Leach, Colin A., et al.. (1983). Nucleosides and Nucleotides. Part 21. Synthesis of a Tridecanucleoside Dodecaphosphate Incorporating the Unnatural Base 2 (1 H)‐Pyridone. Helvetica Chimica Acta. 66(2). 639–651. 9 indexed citations
14.
Trost, Barry M., Peter Bühlmayer, & Michael K. Mao. (1982). An unusual effect of selenium substituents on the regiochemistry of a baeyer-villiger rearrangement. Tetrahedron Letters. 23(14). 1443–1446. 7 indexed citations
15.
Bühlmayer, Peter, et al.. (1980). Nucleoside und Nucleotide. Teil 14. Synthese des Octanucleosidheptaphosphats d(G‐A‐T‐T‐T‐T‐G‐A). Helvetica Chimica Acta. 63(8). 2469–2487. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026